Search

everythinglearnresearchcommunity

for

Search:↓

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Chromosomal microarray analysis is important for diagnosing rare genetic variations and guiding treatment.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

Disrupting the Flcn gene in mice causes early kidney cysts and tumors, which can be treated with rapamycin.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Enhancing immune response can improve cancer treatment effectiveness.

A new protein was made to detect specific skin cell growth receptors and worked in normal skin but not in skin cancer cells.

Cepharanthine helps reduce cell aging caused by the cancer drug Doxorubicin by boosting cell cleanup processes.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.

Alopecia areata involves unique activation of certain immune cells.

CD80 on skin stem cells helps expand Treg cells to aid wound healing.

The assay effectively identifies compounds that affect immune cell activation.

Neutropenic patients show significant changes in immune cell types and lower neutrophil and natural killer cell percentages.

CD206+ macrophages are crucial for hair growth in alopecia areata treatment.

CXCL7 is essential for muscle repair by aiding early neutrophil infiltration.

Severe CCCA may be biologically and clinically different from milder forms.

Inhibiting ODC can prevent UV-induced skin cancer.

Circular RNA ERCC6 helps activate stem cells important for cashmere goat hair growth by interacting with specific molecules in an m6A modification-dependent way.

A 589 nm laser increases IL-2 and IFN-y gene expression in human T-cells.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

A substance called poly(I:C) increases a protein called carbonic anhydrase II in skin cells, which might help with skin defense and healing.

IL-18 signaling helps mature Tregs move into the thymus.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Overexpressing CtBP1 in skin cells causes skin and hair problems.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Dysplastic nevi have unique gene expressions, making them distinct from common melanocytic nevi.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.